The estimated Net Worth of Stephen Berenson is at least 2.27 百万$ dollars as of 3 May 2024. Mr. Berenson owns over 732 units of Moderna Inc stock worth over 1,765,361$ and over the last 6 years he sold MRNA stock worth over 0$. In addition, he makes 500,000$ as Non-Executive Independent Director at Moderna Inc.
Sign up
Mr. Berenson MRNA stock SEC Form 4 insiders trading
Stephen has made over 3 trades of the Moderna Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 732 units of MRNA stock worth 58,201$ on 3 May 2024.
The largest trade he's ever made was exercising 732 units of Moderna Inc stock on 3 May 2024 worth over 58,201$. On average, Stephen trades about 124 units every 43 days since 2018. As of 3 May 2024 he still owns at least 22,203 units of Moderna Inc stock.
You can see the complete history of Mr. Berenson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stephen Berenson biography
Stephen Berenson serves as Non-Executive Independent Director of the Company. Mr. Berenson is a Managing Partner at Flagship Pioneering. Prior to that, Mr. Berenson spent 33 years as an investment banker at J.P. Morgan. During his last twelve years at J.P. Morgan, Mr. Berenson was Vice Chairman of Investment Banking and focused on providing high-touch strategic advice and complex transaction execution to leading companies across all industries globally. He was co-founder of J.P. Morgan’s Global Strategic Advisory Council and co-founder of the firm’s Board Initiative. Mr. Berenson also serves as Chairman of the board of directors of Seres Therapeutics, Inc. (Nasdaq: MCRB) and on the board of directors of CiBO Technologies, Inc. Mr. Berenson received an S.B. in mathematics from MIT.
What is the salary of Stephen Berenson?
As the Non-Executive Independent Director of Moderna Inc, the total compensation of Stephen Berenson at Moderna Inc is 500,000$. There are 13 executives at Moderna Inc getting paid more, with Stephane Bancel having the highest compensation of 8,948,210$.
How old is Stephen Berenson?
Stephen Berenson is 59, he's been the Non-Executive Independent Director of Moderna Inc since 2017. There are 4 older and 14 younger executives at Moderna Inc. The oldest executive at Moderna Inc is Elizabeth Tallett, 71, who is the Director.
What's Stephen Berenson's mailing address?
Stephen's mailing address filed with the SEC is C/O SERES THERAPEUTICS, INC., 101 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MA, 02140.
Insiders trading at Moderna Inc
Over the last 6 years, insiders at Moderna Inc have traded over 2,713,086,305$ worth of Moderna Inc stock and bought 52,631 units worth 999,989$ . The most active insiders traders include Noubar Afeyan、David M. Rubenstein、Stephane Bancel. On average, Moderna Inc executives and independent directors trade stock every 2 days with the average trade being worth of 2,841,687$. The most recent stock trade was executed by Shannon Thyme Klinger on 6 September 2024, trading 1,139 units of MRNA stock currently worth 90,562$.
What does Moderna Inc do?
moderna is pioneering messenger rna therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. this breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions. moderna has developed a broad intellectual property estate including more than 200 patent applications with more than 10,000 claims ranging from novel nucleotide chemistries to specific drug compositions. the company plans to develop and commercialize its innovative mrna drugs—initially for rare diseases and oncology—while partnering drug candidates in other therapeutics areas in order to rapidly deliver this innovation to patients. based in cambridge, massachusetts, moderna is privately held and was founded in 2010 by flagship venturelabs in association with leading scientists from boston children’s hospital a
What does Moderna Inc's logo look like?
Complete history of Mr. Berenson stock trades at Seres Therapeutics Inc、Moderna Inc
Moderna Inc executives and stock owners
Moderna Inc executives and other stock owners filed with the SEC include:
-
Stephane Bancel,
Chief Executive Officer, Director -
Stephen Hoge,
President -
Tal Zvi Zaks,
Chief Medical Officer -
Juan Andres,
Chief Technical Operations and Quality Officer -
Stephane Bancel,
CEO & Director -
Stéphane Bancel,
CEO & Director -
Dr. Stephen Hoge M.D.,
Pres -
Dr. Stephen Hoge,
Pres -
Juan Andres,
Chief Technical Operations & Quality Officer -
David W. Meline,
CFO & Principal Accounting Officer -
Francois Nader,
Non-Executive Independent Director -
Noubar Afeyan,
Non-Executive Independent Chairman of the Board, Co-Founder -
Israel Ruiz,
Non-Executive Independent Director -
Robert Langer,
Non-Executive Independent Director -
Stephen Berenson,
Non-Executive Independent Director -
Paul Sagan,
Non-Executive Independent Director -
Dr. Noubar B. Afeyan Ph.D.,
Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board -
Elizabeth Tallett,
Director -
Ray Jordan,
Chief Corporate Affairs Officer -
Marcello Damiani,
Chief Digital and Operational Excellence Officer -
Lori Henderson,
General Counsel, Company Secretary -
Tracey Franklin,
Chief Human Resource Officer -
David Meline,
Chief Financial Officer -
Colleen Hussey,
Sr. Mang. of Corp. Communications -
Shannon Thyme Klinger,
Chief Legal Officer & Corp. Sec. -
Lori M. Henderson J.D., Esq.,
Gen. Counsel & Corp. Sec. -
Lavina Talukdar CFA,
Sr. VP & Head of Investor Relations -
Dr. Melissa J. Moore,
Chief Scientific Officer & Member of Scientific Advisory Board -
Dr. John V. W. Reynders,
Chief Information Officer -
Lorence H. Kim,
Chief Financial Officer -
Elizabeth G Nabel,
Director -
Noubar Flagship Ventures Fu...,
-
Shannon Thyme Klinger,
Chief Legal Officer -
Jennifer Ling Lee,
Chief Accounting Officer -
Sandra Horning,
Director -
Peter Barton Hutt,
Director -
Moncef Slaoui,
Director -
Ventures Fund Iv General Pa...,
-
Edwin M Jr Kania,
10% owner -
Ventures Fund Iv General Pa...,
-
Goff Corinne Le,
Chief Commercial Officer -
Paul Burton,
Chief Medical Officer -
James M Mock,
Chief Financial Officer -
Arpa Garay,
Chief Commercial Officer -
David M. Rubenstein,
Director